CO6180429A2 - Agente farmaceutico que contiene un inhibidor de her2 y un agente terapeutico hormonal o agente anticancerigeno en combinacion - Google Patents
Agente farmaceutico que contiene un inhibidor de her2 y un agente terapeutico hormonal o agente anticancerigeno en combinacionInfo
- Publication number
- CO6180429A2 CO6180429A2 CO09045382A CO09045382A CO6180429A2 CO 6180429 A2 CO6180429 A2 CO 6180429A2 CO 09045382 A CO09045382 A CO 09045382A CO 09045382 A CO09045382 A CO 09045382A CO 6180429 A2 CO6180429 A2 CO 6180429A2
- Authority
- CO
- Colombia
- Prior art keywords
- optionally substituted
- agent
- atom
- optionally
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1.- Un agente farmacéutico caracterizado porque comprende (1) un inhibidor de HER2 que tiene un esqueleto de pirrolopirimidina o de pirazolopirimidina y (2) un agente terapéutico hormonal o agente anticancerígeno en combinación. 2.- El agente farmacéutico de acuerdo con la reivindicación 1, caracterizado porque el inhibidor de HER2 que tiene un esqueleto de pirrolopirimidina o de pirazolopirimidina es un compuesto representado por la fórmula:en donde W es C(R1) o N,A es un grupo arilo sustituido opcionalmente o un grupo heteroarilo sustituido opcionalmente, X1 es -NR3-Y1-, -O-, -S-, -SO-, -SO2- o -CHR3- en donde R3 es un átomo de hidrógeno o un grupo hidrocarburo alifático sustituido opcionalmente, o R3 está unido opcionalmente a un átomo de carbono o un heteroátomo en el grupo arilo o el grupo heteroarilo representado por A para formar una estructura anular sustituida opcionalmente, y Y1 es un enlace simple o un alquileno C1-4 sustituido opcionalmente o un -O- (alquileno C1-4)- sustituido opcionalmente, R1 es un átomo de hidrógeno o un grupo sustituido unido opcionalmente a través de un átomo de carbono, un átomo de nitrógeno o un átomo de oxígeno, y R2 es un átomo de hidrógeno o un grupo sustituido unido opcionalmente a través de un átomo de carbono o un átomo de azufre, o R1 y R2, o R2 y R3 están unidos opcionalmente para formar una estructura anular sustituida opcionalmente, con la condición de que se excluyan los compuestos representados por las fórmulas:o una de sus sales o uno de sus profármacos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006275841 | 2006-10-06 | ||
JP2007057902 | 2007-03-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6180429A2 true CO6180429A2 (es) | 2010-07-19 |
Family
ID=39283276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09045382A CO6180429A2 (es) | 2006-10-06 | 2009-05-06 | Agente farmaceutico que contiene un inhibidor de her2 y un agente terapeutico hormonal o agente anticancerigeno en combinacion |
Country Status (23)
Country | Link |
---|---|
US (1) | US20100008912A1 (es) |
EP (2) | EP2063895A2 (es) |
JP (1) | JP2010505745A (es) |
KR (1) | KR20090094804A (es) |
CN (1) | CN101553222A (es) |
AR (1) | AR063152A1 (es) |
AU (1) | AU2007307489A1 (es) |
BR (1) | BRPI0717477A2 (es) |
CA (1) | CA2665692A1 (es) |
CL (1) | CL2007002878A1 (es) |
CO (1) | CO6180429A2 (es) |
CR (1) | CR10759A (es) |
EA (1) | EA200970353A1 (es) |
EC (1) | ECSP099311A (es) |
GE (1) | GEP20115218B (es) |
IL (1) | IL197883A0 (es) |
MA (1) | MA30815B1 (es) |
MX (1) | MX2009003660A (es) |
NO (1) | NO20091628L (es) |
PE (1) | PE20080977A1 (es) |
TN (1) | TN2009000119A1 (es) |
TW (1) | TW200823218A (es) |
WO (1) | WO2008044782A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005118588A1 (ja) * | 2004-06-02 | 2005-12-15 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物 |
JPWO2008156153A1 (ja) | 2007-06-19 | 2010-08-26 | 武田薬品工業株式会社 | 癌の予防・治療剤 |
US8946239B2 (en) | 2008-07-10 | 2015-02-03 | Duquesne University Of The Holy Spirit | Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof |
WO2011040212A1 (en) | 2009-10-01 | 2011-04-07 | Takeda Pharmaceutical Company Limited | Therapeutic agent for brain tumor |
KR101592258B1 (ko) * | 2014-06-20 | 2016-02-05 | 보령제약 주식회사 | 제제 및 이의 제조방법 |
US10215341B2 (en) * | 2016-08-09 | 2019-02-26 | Baker Hughes, A Ge Company, Llc | Facilitating the transition between flooding and hydrotesting with the use of an intelligent pig |
KR20220156862A (ko) * | 2020-03-17 | 2022-11-28 | 마이크로벤션, 인코포레이티드 | 액체 색전제 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU33730B (en) * | 1967-04-18 | 1978-02-28 | Farmaceutici Italia | Process for preparing a novel antibiotic substance and salts thereof |
JPS6019790A (ja) * | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
JP3040121B2 (ja) * | 1988-01-12 | 2000-05-08 | ジェネンテク,インコーポレイテッド | 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法 |
US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
TW200412966A (en) * | 2002-09-04 | 2004-08-01 | Schering Corp | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
JP4366683B2 (ja) | 2003-07-28 | 2009-11-18 | 武原 力 | 熱サイホン |
WO2005118588A1 (ja) * | 2004-06-02 | 2005-12-15 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物 |
JP2008501708A (ja) | 2004-06-04 | 2008-01-24 | スミスクライン ビーチャム (コーク) リミテッド | がんの治療方法 |
AU2005281704A1 (en) * | 2004-09-06 | 2006-03-16 | Nycomed Gmbh | Novel pyrazolopyrimidines |
JP2006275841A (ja) | 2005-03-30 | 2006-10-12 | Taiheiyo Cement Corp | セメント中のジエチレングリコール量の定量方法 |
JP2007057902A (ja) | 2005-08-25 | 2007-03-08 | Seiko Epson Corp | 画像形成装置 |
-
2007
- 2007-10-05 MX MX2009003660A patent/MX2009003660A/es not_active Application Discontinuation
- 2007-10-05 CA CA002665692A patent/CA2665692A1/en not_active Abandoned
- 2007-10-05 EP EP07829761A patent/EP2063895A2/en not_active Withdrawn
- 2007-10-05 PE PE2007001354A patent/PE20080977A1/es not_active Application Discontinuation
- 2007-10-05 EP EP11156096A patent/EP2359825A2/en not_active Withdrawn
- 2007-10-05 US US12/444,309 patent/US20100008912A1/en not_active Abandoned
- 2007-10-05 CL CL200702878A patent/CL2007002878A1/es unknown
- 2007-10-05 KR KR1020097009034A patent/KR20090094804A/ko not_active Application Discontinuation
- 2007-10-05 WO PCT/JP2007/070026 patent/WO2008044782A2/en active Application Filing
- 2007-10-05 EA EA200970353A patent/EA200970353A1/ru unknown
- 2007-10-05 CN CNA2007800453762A patent/CN101553222A/zh active Pending
- 2007-10-05 TW TW096137401A patent/TW200823218A/zh unknown
- 2007-10-05 BR BRPI0717477-2A patent/BRPI0717477A2/pt not_active IP Right Cessation
- 2007-10-05 GE GEAP200711244A patent/GEP20115218B/en unknown
- 2007-10-05 AU AU2007307489A patent/AU2007307489A1/en not_active Abandoned
- 2007-10-05 JP JP2009514289A patent/JP2010505745A/ja not_active Abandoned
- 2007-10-09 AR ARP070104424A patent/AR063152A1/es not_active Application Discontinuation
-
2009
- 2009-04-03 TN TNP2009000119A patent/TN2009000119A1/fr unknown
- 2009-04-05 IL IL197883A patent/IL197883A0/en unknown
- 2009-04-23 NO NO20091628A patent/NO20091628L/no not_active Application Discontinuation
- 2009-04-27 MA MA31822A patent/MA30815B1/fr unknown
- 2009-04-30 CR CR10759A patent/CR10759A/es unknown
- 2009-05-05 EC EC2009009311A patent/ECSP099311A/es unknown
- 2009-05-06 CO CO09045382A patent/CO6180429A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TN2009000119A1 (en) | 2010-10-18 |
EA200970353A1 (ru) | 2009-10-30 |
BRPI0717477A2 (pt) | 2015-06-16 |
IL197883A0 (en) | 2009-12-24 |
EP2063895A2 (en) | 2009-06-03 |
MA30815B1 (fr) | 2009-10-01 |
GEP20115218B (en) | 2011-05-25 |
CL2007002878A1 (es) | 2008-08-01 |
EP2359825A2 (en) | 2011-08-24 |
AU2007307489A1 (en) | 2008-04-17 |
MX2009003660A (es) | 2009-04-22 |
ECSP099311A (es) | 2009-06-30 |
AR063152A1 (es) | 2008-12-30 |
KR20090094804A (ko) | 2009-09-08 |
NO20091628L (no) | 2009-06-26 |
US20100008912A1 (en) | 2010-01-14 |
TW200823218A (en) | 2008-06-01 |
CR10759A (es) | 2009-05-27 |
WO2008044782A3 (en) | 2008-12-11 |
JP2010505745A (ja) | 2010-02-25 |
CA2665692A1 (en) | 2008-04-17 |
CN101553222A (zh) | 2009-10-07 |
PE20080977A1 (es) | 2008-09-05 |
WO2008044782A2 (en) | 2008-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6180429A2 (es) | Agente farmaceutico que contiene un inhibidor de her2 y un agente terapeutico hormonal o agente anticancerigeno en combinacion | |
UY29886A1 (es) | Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones | |
CL2009000429A1 (es) | Compuestos derivados de carbamoil-heterociclos fusionados, en especial pirrolo[3,2-c]piridin-2-carboxamidas, inhibidores de smo; composicion farmaceutica que comprende dichos compuestos; y uso en la profilaxis o tratamiento del cancer. | |
CO6321248A2 (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
AR048641A1 (es) | Compuestos de aril- o heteroarilamida ortosustituidos utiles como antago-nistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicame | |
AR082826A2 (es) | Inhibidores heterociclicos de mek, composiciones farmaceuticas que los contienen, usos, y metodos de preparacion de los mismos | |
UY29360A1 (es) | Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones. | |
AR078152A1 (es) | Compuestos heterociclicos, utiles para el tratamiento de hcv y composiciones farmaceuticas que los comprenden | |
AR059957A1 (es) | DERIVADOS DE ESPIROINDOLINONA, MÉTODOS PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DEL CÁNCER. | |
UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
AR065806A1 (es) | Derivados de quinolina, procesos para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de la artritis reumatoidea. | |
AR063602A1 (es) | Derivados de espiroindolinona, formulaciones farmaceuticas que los contienen y su uso en la obtencion de un medicamento para el tratamiento de trastornos oncologicos. | |
AR064246A1 (es) | Derivados de 5h-pirimido[5,4-d][2]benzazepinas inhibidores de la progresion mitotica,composiciones farmaceuticas que los contienen y usos como agentes anticancer. | |
ECSP099335A (es) | Compuestos heterocíclicos que contienen nitrógeno y métodos de uso de los mismos | |
AR049711A1 (es) | Compuestos heterociclicos condensados como inhibidores de la aldosterona sintasa; composiciones farmaceuticas que los contienen y su uso en la preparacion de un medicamento para el tratamiento o prevencion de enfermedades relacionadas con el hiperaldosterismo y por una liberacion excesiva de cortiso | |
UY29818A1 (es) | Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos | |
UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
AR033793A1 (es) | Compuestos derivados del benceno, su utilizacion, procedimientos para su preparacion y composiciones farmaceuticas que los contienen | |
AR056025A1 (es) | Compuestos de imidazol sustituidos como inhibidores de ksp | |
UY29844A1 (es) | Formulación en aerosol para la inhalación de beta-agonistas | |
UY29070A1 (es) | Enantiómeros de heterocíclicos fusionados y sus usos | |
UY29003A1 (es) | Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
UY29169A1 (es) | Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica | |
AR045155A1 (es) | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos | |
SV2004001555A (es) | Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |